LianBio LIANY Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.04 unchanged at close Nov 6
Last close · Previous close $0.04
- Market cap
- At the Nov 6 close
- P/E ratio
- n/mLoss over last 12 months
- Diluted EPS
- −$0.81Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.04down $0.02, 35.81%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.04Nov 5
- Volume2.00Nov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume2.61KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.02 to $0.18; now $0.04
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
LIANY trailed the S&P 500 in all 6 periods.
| Period | LIANY and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | LIANY: down 35.8% S&P 500: down 5.6% | LIANY trailed the S&P 500 by 30.2 percentage points Trailed |
| 3M | LIANY: down 15.7% S&P 500: down 4.1% | LIANY trailed the S&P 500 by 11.6 percentage points Trailed |
| YTD | LIANY: down 59.2% S&P 500: up 8.7% | LIANY trailed the S&P 500 by 67.9 percentage points Trailed |
| 1Y | LIANY: down 54.6% S&P 500: up 10.9% | LIANY trailed the S&P 500 by 65.5 percentage points Trailed |
| Long term | ||
| 3Y | LIANY: up 46.8% S&P 500: up 75.0% +13.6% vs +20.5% a year | LIANY trailed the S&P 500 by 28.2 percentage points Trailed |
| 5Y | LIANY: down 57.9% S&P 500: up 67.8% −15.9% vs +10.9% a year | LIANY trailed the S&P 500 by 125.7 percentage points Trailed |
$10,000 invested in LIANY 5 years ago (Nov 5, 2021) would be worth about $4,207 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,782.
LIANY trailed the S&P 500 in all 6 periods.
| Period | LIANY and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | LIANY: down 35.8% S&P 500: down 5.6% | LIANY trailed the S&P 500 by 30.2 percentage points Trailed |
| 3M | LIANY: down 15.7% S&P 500: down 4.3% | LIANY trailed the S&P 500 by 11.4 percentage points Trailed |
| YTD | LIANY: down 59.2% S&P 500: up 7.8% | LIANY trailed the S&P 500 by 67.0 percentage points Trailed |
| 1Y | LIANY: down 54.6% S&P 500: up 9.7% | LIANY trailed the S&P 500 by 64.3 percentage points Trailed |
| Long term | ||
| 3Y | LIANY: down 99.1% S&P 500: up 68.8% −78.9% vs +19.1% a year | LIANY trailed the S&P 500 by 167.9 percentage points Trailed |
| 5Y | LIANY: down 99.7% S&P 500: up 56.9% −69.4% vs +9.4% a year | LIANY trailed the S&P 500 by 156.6 percentage points Trailed |
$10,000 invested in LIANY 5 years ago (Nov 5, 2021) would be worth about $27 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,694.
All-time high
$16.20
Closing high on . Now 99.8% below that record.
Split-adjusted daily closes since Nov 1, 2021.
Stock splits
LIANY hasn’t split since its price history begins in 2021.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY23, the quarter ended Sep 30, 2023. “Last 12 months” means the four quarters from Oct 1, 2022 to Sep 30, 2023, and balance-sheet figures are as of Sep 30, 2023.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $0.00
- Net income
- −$87.98M
- Diluted EPS
- −$0.81
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY21 (Dec 31, 2021) | $0.00 | −$21.20M | $2.81 |
| Q1 FY22 (Mar 31, 2022) | $0.00 | −$27.73M | −$0.26 |
| Q2 FY22 (Jun 30, 2022) | $0.00 | −$42.39M | −$0.39 |
| Q3 FY22 (Sep 30, 2022) | $0.00 | −$21.90M | −$0.20 |
| Q4 FY22 (Dec 31, 2022) | $0.00 | −$18.28M | −$0.17 |
| Q1 FY23 (Mar 31, 2023) | $0.00 | −$24.05M | −$0.22 |
| Q2 FY23 (Jun 30, 2023) | $0.00 | −$21.62M | −$0.20 |
| Q3 FY23 (Sep 30, 2023) | $0.00 | −$24.04M | −$0.22 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY20 (Dec 31, 2020) | $0.00 | −$139.60M | −$11.58 |
| FY21 (Dec 31, 2021) | $0.00 | −$196.30M | −$5.71 |
| FY22 (Dec 31, 2022) | $0.00 | −$110.29M | −$1.02 |
Margins
- Gross —
- Operating —
- Net —
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$83.99MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$83.53MLast 12 months
- Capital spending$464.00KLast 12 months
Shareholder returns
- $0.00Last 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
Balance sheet
- $252.29MAs of Sep 30, 2023
Cash plus short- and long-term marketable securities on the Sep 30, 2023 balance sheet.
- Total debt$2.84MAs of Sep 30, 2023
- Net cash$249.45MAs of Sep 30, 2023
- 10.06As of Sep 30, 2023
Current assets divided by current liabilities on the Sep 30, 2023 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.01As of Sep 30, 2023
Total debt divided by shareholders’ equity on the Sep 30, 2023 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- −38.1%Last 12 months
Over the last 12 months, LianBio lost money: its net loss was 38.1% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - −30.2%Last 12 months
Over the last 12 months, LianBio’s net loss was 30.2% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.000 |
| 2017 | $0.000 |
| 2018 | $0.000 |
| 2019 | $0.000 |
| 2020 | $0.000 |
| 2021 | $0.000 |
| 2022 | $0.000 |
| 2023 | $0.000 |
| 2024 | $4.80 |
| 2025 | $0.43 |
| 2026 (to date) | $0.000 |
Dividend details
- $0.00Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- Dividend yield0.00%Last 12 months
- $0.43Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyAnnual0 payments in the last 12 months
About LianBio
LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in China and other Asian markets.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New Jersey, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
LIANY news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
LIANY stock FAQ
What is LIANY stock’s price today?
LianBio (LIANY) traded at $0.04 at the close on , unchanged from the previous close of $0.04. Over the past 52 weeks it has traded between $0.02 and $0.18.
If you invested $1,000 in LIANY 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in LIANY on would be worth about $421 at the close on , a total return of −57.9%. The same $1,000 would be worth $454 if invested one year ago. Past performance doesn’t predict future returns.
What is LIANY’s P/E ratio?
LIANY’s P/E ratio isn’t meaningful right now because its earnings over the four quarters to are negative (diluted EPS of −$0.81).
What are LIANY’s earnings per share?
LIANY’s diluted earnings per share were −$0.81 over the four quarters to , compared with $1.96 in the twelve months before. The latest quarter (Q3 FY23) brought −$0.22 per share, against −$0.20 a year earlier (how EPS works).
Does LIANY pay a dividend?
LianBio hasn’t paid a dividend in the last twelve months.
What is LIANY’s 52-week high and low?
Over the past 52 weeks LIANY has traded as low as $0.02 and as high as $0.18. At $0.04 at the close on , it is 78.1% below that high and 83.9% above the low.
What is LIANY’s all-time high?
LIANY’s highest closing price was $16.20 on , adjusted for stock splits. At $0.04 at the close on , it is 99.8% below that record.
Has LIANY stock ever split?
No. LIANY hasn’t split since its price history begins in 2021.
How has LIANY stock performed?
Including dividends and measured to the close on , LIANY has returned −59.2% so far this year and −54.6% over the past year, and −57.9% over five years (−15.9% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is LianBio in?
LianBio is in the Healthcare sector and the Biotechnology industry, and is headquartered in New Jersey, USA.
What exchange does LIANY trade on?
LianBio trades on the PINK under the ticker symbol LIANY. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.